Literature DB >> 8254759

Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.

M G Agadjanyan1, K E Ugen, B Wang, W V Williams, D B Weiner.   

Abstract

Human T-cell leukemia virus type I and type II (HTLV-I and HTLV-II, respectively) infect certain sublines of the BJAB human B-cell line. We observed that the WH subline, but not the CC/84 subline, of BJAB cells were infectible by cell-free HTLV-I or HTLV-II and formed syncytia with cells infected by these retroviruses. This suggests that the BJAB-CC/84 cells possibly lack a membrane molecule(s) important for syncytium formation and infectibility. In order to identify this antigen, we generated polyclonal anti-BJAB-WH antisera which were adsorbed on BJAB-CC/84 cells. The adsorbed antisera bound only BJAB-WH and BJAB-CC/79 cells as demonstrated by complement-dependent cytotoxicity and flow cytometric assays. Furthermore, this adsorbed antisera bound several human T-cell clones, including SupT-1, as determined by flow cytometric assays. The adsorbed antiserum was monospecific as it immunoprecipitated only one 78- to 80-kDa protein from lysates of metabolically labeled BJAB-WH, BJAB-CC/79, and SupT-1, but not BJAB-CC/84, cells. The monospecific antisera detected a glycoprotein composed of a 64- to 66-kDa core protein containing tunicamycin-sensitive N-linked oligosaccharides. This membrane glycoprotein appears to be involved in HTLV-I- and HTLV-II-induced fusion and infection, as the monospecific antisera were capable of inhibiting both of these processes. The monospecific antisera diluted 1:50 and 1:90 inhibited 85 to 90% of syncytium formation induced in BJAB-WH, BJAB-CC/79, and SupT-1 cells cultured with HTLV-I- or HTLV-II-infected MT2, MoT, or FLW human T- or B-cell lines. At the same dilution, antisera inhibited 70 to 80% of infection of BJAB-WH cells by cell-free HTLV-I or HTLV-II. Thus, these studies indicate a role for a 78- to 80-kDa glycoprotein in HTLV-I or HTLV-II infection and syncytium formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254759      PMCID: PMC236309     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.

Authors:  D B Weiner; J Liu; J A Cohen; W V Williams; M I Greene
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

3.  Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: parameters of virus integration and expression.

Authors:  A de Rossi; A Aldovini; G Franchini; D Mann; R C Gallo; F Wong-Staal
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

Review 4.  Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains.

Authors:  A D Elbein
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

6.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

7.  Specific adsorption of HTLV-I to various target human and animal cells.

Authors:  K Krichbaum-Stenger; B J Poiesz; P Keller; G Ehrlich; J Gavalchin; B H Davis; J L Moore
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

8.  A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis.

Authors:  G D Ehrlich; F R Davey; J J Kirshner; J J Sninsky; S Kwok; D J Slamon; R Kalish; B J Poiesz
Journal:  Am J Hematol       Date:  1989-03       Impact factor: 10.047

9.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

10.  Human T cell leukemia viruses use a receptor determined by human chromosome 17.

Authors:  M A Sommerfelt; B P Williams; P R Clapham; E Solomon; P N Goodfellow; R A Weiss
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  9 in total

Review 1.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

2.  Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.

Authors:  B Poon; I S Chen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 3.  Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Authors:  Kenneth E Ugen; Susan B Nyland
Journal:  Springer Semin Immunopathol       Date:  2006-10-13

4.  Analysis of human T-cell leukemia virus type 1 particles by using cryo-electron tomography.

Authors:  Sheng Cao; José O Maldonado; Iwen F Grigsby; Louis M Mansky; Wei Zhang
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

5.  71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.

Authors:  Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.

Authors:  Jean-Stéphane Gatot; Isabelle Callebaut; Carine Van Lint; Dominique Demonté; Pierre Kerkhofs; Daniel Portetelle; Arsène Burny; Luc Willems; Richard Kettmann
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation.

Authors:  P L Green; T M Ross; I S Chen; S Pettiford
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.

Authors:  J E Hildreth
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Pathways of cell-cell transmission of HTLV-1.

Authors:  Claudine Pique; Kathryn S Jones
Journal:  Front Microbiol       Date:  2012-10-24       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.